Skip to main content
Erschienen in: Surgical Endoscopy 2/2024

Open Access 26.12.2023 | Guidelines

An international Delphi consensus for surgical quality assessment of lymphadenectomy and anastomosis in minimally invasive total gastrectomy for gastric cancer

verfasst von: Amila Cizmic, Ivan Romic, Andrea Balla, Nicolò Barabino, Gabriele Anania, Gian Luca Baiocchi, Branko Bakula, Carmen Balagué, Felix Berlth, Vasile Bintintan, Umberto Bracale, Jan-Hendrik Egberts, Hans F. Fuchs, Suzanne S. Gisbertz, Ines Gockel, Peter Grimminger, Richard van Hillegersberg, Noriyuki Inaki, Arul Immanuel, Daniel Korr, Philipp Lingohr, Pietro Mascagni, Nathaniel Melling, Marco Milone, Yoav Mintz, Salvador Morales-Conde, Yusef Moulla, Beat P. Müller-Stich, Kiyokazu Nakajima, Magnus Nilsson, Matthias Reeh, Pierpaolo Sileri, Eduardo M. Targarona, Yuki Ushimaru, Young-Woo Kim, Sheraz Markar, Felix Nickel, Anuja T. Mitra

Erschienen in: Surgical Endoscopy | Ausgabe 2/2024

Abstract

Background

Minimally invasive total gastrectomy (MITG) is a mainstay for curative treatment of patients with gastric cancer. To define and standardize optimal surgical techniques and further improve clinical outcomes through the enhanced MITG surgical quality, there must be consensus on the key technical steps of lymphadenectomy and anastomosis creation, which is currently lacking. This study aimed to determine an expert consensus from an international panel regarding the technical aspects of the performance of MITG for oncological indications using the Delphi method.

Methods

A 100-point scoping survey was created based on the deconstruction of MITG into its key technical steps through local and international expert opinion and literature evidence. An international expert panel comprising upper gastrointestinal and general surgeons participated in multiple rounds of a Delphi consensus. The panelists voted on the issues concerning importance, difficulty, or agreement using an online questionnaire. A priori consensus standard was set at > 80% for agreement to a statement. Internal consistency and reliability were evaluated using Cronbach's α.

Results

Thirty expert upper gastrointestinal and general surgeons participated in three online Delphi rounds, generating a final consensus of 41 statements regarding MITG for gastric cancer. The consensus was gained from 22, 12, and 7 questions from Delphi rounds 1, 2, and 3, which were rephrased into the 41 statetments respectively. For lymphadenectomy and aspects of anastomosis creation, Cronbach’s α for round 1 was 0.896 and 0.886, and for round 2 was 0.848 and 0.779, regarding difficulty or importance.

Conclusions

The Delphi consensus defined 41 steps as crucial for performing a high-quality MITG for oncological indications based on the standards of an international panel. The results of this consensus provide a platform for creating and validating surgical quality assessment tools designed to improve clinical outcomes and standardize surgical quality in MITG.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1007/​s00464-023-10614-9.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Gastric cancer accounts for Europe's fourth highest cause of cancer-related deaths, and its incidence is projected to rise globally [13]. The mainstay of curative treatment is surgical resection with corresponding en-bloc D2 lymphadenectomy (LND) [4, 5]. International adoption of minimally invasive techniques in treating gastric cancer has been observed [611]. First performed by Kitano [12], it has subsequently been evaluated in several large-scale randomized controlled trials (RCTs) in the Asian continent [1316] and corroborated in high-quality European population-based studies and RCTs [17, 18]. Outcomes from these studies have advocated the use of minimally invasive total gastrectomy (MITG) by demonstrating superiority in short- and long-term general surgical outcomes such as post-operative length of stay [4, 15, 19] and equivalence of MITG for oncological specific outcomes. Multicenter studies such as the LOGICA and the STOMACH trials demonstrated the feasibility and oncological efficacy of MITG compared to open surgery and subsequently recommended this approach to improve long-term outcomes [17, 2022].
For oncological indications, key technical steps specific to gastric cancer must be respected, such as the extent and the number of lymph nodes harvested and achieving an R0 resection margin. Therefore, MITG for oncological treatment is considered an advanced minimally invasive procedure as it involves achieving complete en-bloc dissection of lymph node stations and creating a high-quality anastomosis [23, 24]. The lack of compliance with the D2 LND in MITG has been reported in several publications and can negatively impact patient outcomes [18, 25, 26]. Combined with the technical challenges, there is heterogeneity within techniques and steps surgeons undertake to achieve a complete oncological MITG. These variations can impact clinical outcomes in patients, complicate reporting and comparing outcomes between studies, hinder the assessment of surgical quality, and pose challenges to the teaching and training of MITG.
The aim of this study was to develop an international expert consensus on the technical steps of LND and general aspects of anastomosis creation in MITG for oncological indications using the Delphi method. The consensus will inform the development of surgical quality assessment tools for MITG and the creation of a technical framework to aid skill acquisition and surgeon training. The consensus will also enable benchmarking of this procedure so practicing surgeons and certifying bodies are ensured that MITG is being performed competently and, most importantly, safely [27].

Materials and methods

This study utilized the Delphi method to achieve consensus by soliciting international expert opinion on essential technical steps in LND and general aspects of anastomosis creation required to perform MITG for oncological indications (Fig. 1). The study utilized the AGREE II framework for the assessment of the methodological quality of practice guidelines (Appendices 1 and 2). AGREE II comprises 23 items organized into six quality domains: (i) scope and purpose; (ii) stakeholder involvement; (iii) rigor of development; (iv) clarity of presentation; (v) applicability; and (vi) editorial independence that targets various aspects of practice guideline quality [28]. The outcomes of this study were to create consensus on the most important steps of the operation required to achieve optimal oncological outcomes, minimize technical heterogeneity, and inform the training of future surgeons.

The Delphi method

The Delphi method was first developed by the RAND Corporation in 1948. It is a structured and iterative process used to acquire knowledge and opinions from experts on a selected topic [29, 30]. The major advantages of using the Delphi method are that a wide range of views can be obtained, which enables the collation of international opinions while being cost-effective and eliminating the need to travel. It also provides a platform for experts to revise their initial opinions based on the feedback from the group, fostering convergence and consensus-building. The anonymous nature of the Delphi method also ensures that a single dominant group member does not inordinately influence the group's outcome [31]. The Delphi method has been widely used in determining guidelines and recommendations in the medical field, especially on topics that lack RCTs as evidence [27, 3234].

Creation of MITG scoping questionnaire

A novel 100-step scoping questionnaire was created by deconstructing the entire MITG procedure into key technical steps focusing on D2 LND and general aspects of anastomosis creation for oncological indications (see Appendices 3, 4, and 5 for the complete questionnaire). The deconstruction of procedures into their individual elements has been described as a validated and effective strategy [35]. The MITG sub-steps were created based on author group consensus, expert supervision from upper gastrointestinal (UGI) surgical faculty at the University Medical Center Hamburg-Eppendorf, Germany, and the University of Oxford, UK, and peer-reviewed published literature. The survey was refined through iterations. The final version consisted of questions related to the demographics of the expert panel, and the remaining questions were categorized into two main groups: questions surrounding LND and general aspects associated with the creation of the anastomosis.

Selection of experts

Expert surgeons in UGI were identified globally to represent an international consensus on performing MITG in Asian and European countries. Experts were selected based on the following inclusion criteria: high case volume defined as > 20 cases per year in their local institution, national or international board accreditations, and individual credentialing of surgeons based on their number of index cases performed as well as specific expertise in methodology. All panelists were identified as experts in their clinical field and currently practicing minimally invasive surgeons. General surgeons were also considered for the expert panel since some countries do not differentiate between subspecialties despite having UGI high case volume centers. In these cases, the determining inclusion factors were the high case volume center and the UGI expertise of the panelists. Thirty participants representing 12 countries were initially approached through e-mail with personalized invitation letters explaining the project. The membership of the expert panel was anonymized.

Delphi rounds

Statements generated in the scoping questionnaire were presented to the expert panel via an online survey on SurveyMonkey® (USA). The questions were divided into three domains depending on the type of possible answers: questions with a 5-point Likert scale regarding the importance of the subject, questions with a 5-point Likert scale regarding the difficulty of the subject, and binary ‘yes’ or ‘no’ questions. An a priori consensus standard was set at > 80% if the panel deemed the statement important and < 40% unimportant. Panelists were also encouraged to suggest additional statements or modifications to the statements in free text fields. Rounds 2 and 3 questions were modified according to the experts' comments and suggestions from previous rounds. Each round was closed once 90% of the experts had responded. Results were analyzed, and those questions that failed to reach consensus were evaluated, rephrased if necessary, and distributed to the same experts for rounds 2 and 3 of the survey, in addition to novel statements generated from the previous rounds. The survey was closed when all responses reached consensus or agreed on non-consensus.

Statistical analysis

Statistical analysis and descriptive statistics were performed using the SPSS software (version 25.0, IBM SPSS Inc., Chicago, Illinois, USA), and data were given as absolute frequency and mean ± standard deviation. Cronbach's α was calculated to determine internal consistency.

Results

Thirty UGI/general surgery experts were invited to participate in the Delphi survey. Twenty-eight (93.3%) experts across 12 countries completed the first, and 25 (83.3%) completed the second and third Delphi round. The demographic characteristics of the experts are presented in Table 1.
Table 1
Demographic characteristics of the Delphi participants (n = 30)
Country of residence n (%)
 
 Germany
10 (33.3)
 Italy
6 (20.0)
 Japan
2 (6.7)
 Spain
3 (10.0)
 Netherlands
2 (6.7)
 Croatia
1 (3.3)
 Israel
1 (3.3)
 Romania
1 (3.3)
 Sweden
1 (3.3)
 Switzerland
1 (3.3)
 United Kingdom
1 (3.3)
 South Korea
1 (3.3)
Specialty
 
 UGI surgery
17 (56.7)
 General surgery
13 (43.3)
Years of experience in MIS
 
 3–5 years
2 (6.7)
 6–10 years
1 (3.3)
 11–15 years
6 (20.0)
 16–20 years
6 (20.0)
 > 20 years
15 (50.0)
n number, UGI upper gastrointestinal, MIS minimally invasive surgery
Seventeen out of 30 experts were UGI surgeons (56.7%), and 13 (43.3%) were general surgeons. The majority of experts had more than 20 years experience in MIS.
The total time needed to complete all three rounds was seven months (11/2022–06/2023). In all three groups, there were 100 questions, 65 with 5-Likert scale answers regarding the importance, 19 with 5-Likert scale answers regarding the difficulty, and 16 with yes or no answers (Table 2).
Table 2
Characteristics of the Delphi rounds
Parameters
Round 1
Round 2
Round 3
Number of participants
28
25
25
The time needed to close the round (months)
4
2
1
Average time spent to finish the survey (min)
19.4
13.4
2.4
Questions in total
69
34
12
Demographic questions
11 (15.9)
2 (6.3)
2 (16.7)
Questions based on difficulty n (%)
12 (17.4)
7 (21.9)
0 (0.0)
Cronbach’s α for questions based on difficulty
0.896
0.848
Questions based on importance n (%)
46 (66.7)
19 (59.4)
0 (0.0)
Cronbach’s α for questions based on importance
0.886
0.779
Questions with y/n answers
0 (0.0)
6 (18.8)
10 (83.3)
Consensus reached n (%)
22 (37.9)
12 (37.5)
7 (70)
Questions that did not reach consensus n (%)
36 (62.1)
20 (62.5)
3 (30)
Questions moved to the next round* n (%)
26 (44.8)
9 (28.1)
0 (0.0)**
Questions excluded n (%)
10 (17.2)
11 (34.4)
0 (0.0)**
n number, y/n yes or no
*Some questions were rephrased into two or more questions
**Last Delphi round
The Cronbach's α for round 1 questions regarding importance (n = 46, 66.7%) was 0.886. For questions regarding the difficulty (n = 12, 17.4%) in round 1, Cronbach's α was 0.896. In round 2, Cronbach's α was 0.779 for questions regarding importance (n = 19, 59.4%) and 0.848 for questions regarding difficulty (n = 7, 21.9%) (Table 2).
Consensus was reached from 22 questions from round 1, 12 from round 2, and 7 from round 3 (Table 2). These were rephrased into 41 consensus statements regarding LND and general aspects of anastomosis creation in MITG (Table 3). The 41 statements were divided into general aspects of the MITG (n = 2), key technical aspects of LND (n = 33), general aspects of LND in MITG (n = 1), and general aspects of anastomosis creation (n = 5) (Table 3).
Table 3
Consensus statements regarding LND and general aspects of the anastomosis creation in MITG
Statements
Cons. (%)
General aspects of the MITG
 
 The division of the gastrocolic ligament is extremely/very important to facilitate LND
96
 Omentectomy can be omitted in MITG in T1/2 tumor stages
84
Station 3
 
 LND station 3 is extremely/very important
86
 LND station 3 at the lesser gastric curvature, reaching cardia and the right crux of the diaphragm, is extremely/very important
89
Station 4d
 
 LND station 4d is extremely/very important in MITG
96
 Identifying the gastroduodenal artery in LND station 4d is extremely/very important
82
 In LND station 4d, it is extremely/very important to follow the gastroduodenal artery to identify the right gastroepiploic artery
82
 Performing the LND station 4d along the distal right gastroepiploic artery is extremely/very important
96
 LND station 4d: It is extremely/very important to ligate the right gastroepiploic artery at its origin
93
 It is extremely/very important to identify and ligate the right gastroepiploic vein and/or the gastrocolic trunk to facilitate the LND of stations 4d and 6
82
Station 11p
 
 LND station 11p is extremely/very important in MITG
86
 Identifying the proximal splenic artery in LND station 11p is extremely/very important
93
Station 4sb
 
 LND station 4sb is extremely/very important in MITG
82
 The identification of the left gastroepiploic vessels is an extremely/very important step toward station 4sb LND
96
 The ligation of the left gastroepiploic artery and vein close to their origin is important in LND station 4sb
84
Station 4sa
 
 LND 4sa is extremely/very important in tumor localization on greater gastric curvature, fundus, or corpus of the stomach
88
 In LND station 4sa, it is extremely/very important to identify and ligate the short gastric vessels
88
 In LND station 4sa, it is extremely/very important to continue the dissection until the angle of His and the left crus of the diaphragm
86
Station 7
 
 LND station 7 is extremely/very important in MITG
100
 In LND 7, it is extremely/very important to retract the vascular pedicle of the stomach upwards to improve visualization and dissect the LGA and LGV
92
 In LND station 7, it is extremely/very important to ligate the LGA at its origin at the celiac trunk
93
 In LND station 7, it is extremely/very important to ligate the LGV at the upper border of the pancreas
84
Station 9
 
 LND station 9 is extremely/very important in MITG
86
Stations 5 and 6
 
 LND of stations 5 and 6 is extremely/very important in MITG
86
 In the LND of stations 5 and 6, it is extremely/very important to dissect the posterior side of the postpyloric part of the duodenum to create a safe passage for the stapler
96
 In the LND of stations 5 and 6, it is extremely/very important to perform a stapled division of the duodenum 1–2 cm postpyloric
89
Stations 8a and 12a
 
 LND stations 8a and 12a are extremely/very important in MITG
82
 In the LND of stations 8a and 12a, the identification of the common hepatic artery is extremely/very important
86
 In the LND of stations 8a and 12a, the identification of the proper hepatic artery by following the superior border of the common hepatic artery is extremely/very important
86
 In LND of stations 8a and 12a, the ligation of the RGA at its origin is extremely/very important
89
Stations 1 and 2
 
 LND of stations 1 and 2 is extremely/very important in MITG
82
 It is extremely/very important to dissect the right (station 1) and left (station 2) paracardial lymph nodes along the right and left crux of the diaphragm
80
Station 10
 
 LND station 10 is extremely/very important for complete oncological dissection in tumors of greater gastric curvature at the level of the spleen
96
 LND station 10 can be omitted for tumors far from the greater gastric curvature and the spleen
92
 LND of the splenic hilum (station 10) is very difficult/difficult in MITG
86
General aspects of LND in MITG
 
 It is extremely/very important that the lymph nodes are intact
82
General aspects of anastomosis in MITG
 
 Skillful creation of the anastomosis is extremely/very important in MITG
100
 Safety and efficiency in creating the anastomosis in MITG are extremely/very important
100
 Tension-free and torsion-free anastomosis in MITG is extremely/very important
93
 The frozen section should be performed if the tumor localization is perceived to be close to the margin
92
 An intraoperative leak test can be performed at the surgeon's discretion to rule out the leakage
80
LND lymphadenectomy, Cons. (%) percentage of answers that reached consensus, MITG minimally invasive total gastrectomy, LGA left gastric artery, LGV left gastric vein, RGA right gastric artery

Statements of non-consensus

A certain number of questions were excluded from rounds 1 and 2 due to either incorporation into the other questions or irrelevance (round 1 n = 10, round 2 n = 11).
Eight questions with a 5-point Likert scale on difficulty performing LND of stations 4sa, 5, 6, 7, 1, 2, 9, 8a, 12a, and 11d required rephrasing due to heterogeneity of answers after rounds 1 and 2 (Table 4). Five questions with a 5-point Likert scale regarding the importance of performing certain MITG steps did not reach an agreement after 3 Delphi rounds, and three questions regarding general aspects of the anastomosis creation with binary responses did not reach consensus (Table 4).
Table 4
Areas of less agreement
Questions regarding importance
EI (%)
I (%)
S (%)
NSI (%)
NI (%)
How important is the omentectomy, irrespective of the tumor stage?
4
8
24
56
8
How important is the omentectomy for advanced tumor stages (T3/T4)?
8
28
36
20
8
How important is identifying the superior mesenteric vein as a necessary step of LND for MITG?
0
12
24
48
16
How important is the station 4sa LND, irrespective of tumor localization?
0
36
52
12
0
Station 11d LND: how important is the division of the posterior gastric vessels at their origin from the splenic artery?
4
52
36
8
0
Questions regarding difficulty
E (%)
V/E (%)
N (%)
D (%)
V/D (%)
How difficult is the LND along the SGV (station 4sa)?
3
32
50
11
4
How difficult is the LND along the inferior and superior border of the duodenum (stations 5 and 6)?
0
18
43
36
3
How difficult is the LND station 7 along the LGA and LGV?
6
20
32
38
4
How difficult are the LNDs of stations 1 and 2?
18
43
32
7
0
How difficult is the LND along the celiac trunk (station 9)?
3
8
39
39
11
How difficult is it to perform a sufficient LND along the common hepatic artery (station 8a)?
0
28
32
28
12
How difficult is it to perform a sufficient LND along the proper hepatic artery (station 12a)?
0
12
28
48
12
How difficult is the LND along the distal splenic artery (station 11d) without splenectomy?
0
4
44
44
8
Questions with y/n answers
Yes (%)
  
No (%)
 
Should the frozen section always be performed if proximal margin resection is less than 6 cm and/or in case of doubt about tumor-free margins?
60
  
40
 
Following neoadjuvant therapy, is an R0 resection oncologically acceptable irrespective of the resection distance from the margin?
68
  
32
 
Should an assessment of the perfusion of the anastomosis be performed with fluorescence or hyperspectral imaging at the discretion of the surgeon?
60
  
40
 
EI extremely important, I important, S somewhat important, NSI not so important, N not at all important, E easy, VE very easy, N neither easy nor difficult, D difficult, VD very difficult, MITG minimally invasive total gastrectomy, LND lymphadenectomy, SGV short gastric vessels, LGA left gastric artery, LGV left gastric vein, y/n yes or no

AGREE II checklist

Two independent assessors evaluated the methodological quality of the guidelines using the AGREE II checklist. Twenty-three items divided into six domains were evaluated based on the practice guidelines (Appendix 1). All domains had a score > 70% defined previously as a quality threshold (domain 1: 92%, domain 2: 78%, domain 3: 84%, domain 4: 92%, domain 5: 75% and domain 6: 96%) (Appendix 2).

Discussion

This is the first international Delphi consensus on the recommended technical steps regarding LND and general aspects of anastomosis creation in MITG for oncological indications. This study aimed to establish and summarize the current recommendations on technical steps required to achieve a high-quality MITG for gastric cancer, explicitly focusing on LND and general anastomosis creation. Thirty international UGI and general surgery experts from 12 countries participated in this study, answering 100 questions through 3 Delphi rounds, generating 41 final recommended statements. The study met the quality threshold of > 70% for all six domains of the AGREE II checklist [28].
The majority of the final consensus statements were attained in round 1 of the Delphi, with high interrater reliability and overall homogeneity in their MITG operating technique. This indicates there was general alignment among how experts perform MITG, validating the selection of our expert panel.
The results of this study identified several issues regarding the importance and perceived difficulty of performing LND in MITG. Statements that commonly reached consensus related to the importance of how to technically approach of the D2 LND steps. The areas of least consensus related to the perceived difficulty of performing LND of specific lymph node stations. For example, 12% of experts rated performing a sufficient LND along the proper hepatic artery (station 12a) as easy, whereas 12% reported it as very difficult. A potential reason for heterogeneous responses on LND difficulty could be the different experience levels of panelists not only with gastrectomy but also with other index procedures that involve similar operative steps or not, such as bariatric surgeries, hiatal hernia repairs, esophagectomies, or pancreatic surgeries, which might influence the difficulty perception of performing specific surgical steps in MITG. However, no difference in the difficulty statement was detected regarding the volume and experience of the panelists. The only ‘difficulty’ statement where the panelists reached agreement was that station 10 LND is extremely/very difficult, which correlates to MITG's challenges regarding the LND of the splenic hilum [36].
Other than defining aspects related to LND in MITG, it was important to determine the general aspects of the procedure, such as omentectomy and division of the gastrocolic ligament. Interestingly, the panelists agreed that performing omentectomy can be omitted in early tumor stages (T1/T2). However, the necessity of omentectomy in advanced stages (T3/T4) or irrespective of tumor stage did not reach consensus after three rounds despite having been recommended in many guidelines and available literature [3740].
The final domain focused on general aspects of anastomosis creation in MITG. Due to the various technical approaches to performing the esophagojejunostomy in MITG, the statements focused on common facets of anastomosis creation rather than choosing one specific way of performing it. The panelists agreed that skillful, safe, efficient, tension- and torsion-free anastomosis is extremely or very important in MITG. The recommendation from round 3 that a frozen section should be performed if the tumor is perceived to be close to the resection margin also reached consensus (92%). However, the panelists could not agree on whether a frozen section should always be performed if the proximal resection margin was less than 6 cm (60% yes vs. 40% no) in round 2. Some surgical steps regarding anastomosis were still heterogenous among panelists, such as whether the R0 resection is oncologically acceptable irrespective of the resection margin distance after neoadjuvant therapy (68% yes vs. 32% no) and regarding the assessment of the perfusion of anastomosis. The panelists were asked whether the assessment of the perfusion of the anastomosis should be performed with indocyanine green fluorescence or a hyperspectral imaging camera, which revealed that 60% of experts stated that it should be performed and 40% of the panel reported it can be omitted. This result may reflect the relatively new use of such perfusion assessment tools in MITG, so the answers may change in the future to reflect the routine incorporation of these tools [41] in case scientific evidence can prove definitive advantages. Regarding the need for anastomosis assessment using an intraoperative leakage test, the panelists reached a consensus that it could be performed at the discretion of the operating surgeon to rule out leakage. This may reflect differences in clinical practice and the absence of evidence in favor of or against routine leak tests. This may also be a statistical problem since intraoperative detection of leaks represents a rather rare finding and thus may be difficult to handle statistically. On the other hand, leak tests may be of clinical value for detecting technical problems while not posing significant risks or added operative time or cost.
The strengths of this study are the solicitation of global expert opinion unifying views across Asia and Europe and the quality and experience of the experts taking part in this consensus. One of the advantages is the high expert response rate (93%) and low attrition rates (10%) between rounds and the high interrater agreement demonstrated by Cronbach's α, strengthening the content validity and effectiveness of the Delphi method. Furthermore, this study addressed a clinically important issue regarding MITG. Determining a sufficient level of agreement with performing an oncologically acceptable MITG is essential for several reasons. MITG is a complex surgical procedure that requires specialized knowledge and skills. The emphasis on compliance in D2 LND has been proven to be of great importance to patient outcomes [18, 25]. Obtaining a consensus from experts in the field ensures that the recommendations and guidelines for performing the procedure are based on the collective wisdom and experience of skilled surgeons. This helps establish a standard of care and minimizes the variability in surgical techniques, leading to standardized patient outcomes. The Delphi method also drives best practices in medicine since consensus-driven guidelines facilitate knowledge of the most effective and evidence-based approaches, leading to improved patient care. This also helps identify potential risks and develop strategies to mitigate them, thereby enhancing patient safety. By standardizing the procedure and promoting adherence to established guidelines, the quality of care provided to patients undergoing MITG can be improved, reducing the likelihood of adverse events and improving surgical safety.
Such consensus-based guidelines can be incorporated into training programs and surgical curricula to ensure that surgeons receive appropriate education and mentoring in MITG, fostering the development of competent and skilled practitioners. Most importantly, this research is essential for innovation. Delphi consensus can guide the direction of future studies, enabling the focus to shift toward the advancement of MITG. Additionally, consensus guidelines may promote innovation by encouraging the evaluation of new techniques, technologies, and approaches through well-designed research studies.
General limitations of the Delphi method and this study should be recognized. Although the Delphi method should be performed with anonymized panelists to mitigate potential bias and enhance quality and objectivity, this study required the identification of the panelists to ensure the participation of the uttermost experts in MITG. The Delphi method may also be susceptible to the ‘groupthink’ phenomena, where participants tend to conform to a dominant viewpoint or consensus rather than providing independent and diverse opinions. One way of mitigating this effect was the conscious decision to conduct the study online. However, this approach did hinder the establishment of meaningful discussions and clarifying responses on site, as panelists could not directly interact or engage in a real-time dialogue with each other or the researchers. Despite this Delphi consensus being created using a scoping strategy with international input, not all aspects of MITG have been addressed, for example, the optimal limb length and the preferences of exact anastomosis technique (e.g., handsewn versus circular stapler versus linear stapler technique) for anastomosis creation. Another limitation of this study is the lack of investigation about technical aspects or approaches; however, these were not the primary aim of the study, and they will be the object of further studies since the current study focused on oncological outcome and perioperative outcome with regards to general surgical technique.
The results of this study represent the first phase of the ANALYTIQs study that resulted from international collaboration in the EAES Research Sandpit in June 2022. The next step is creating a surgical quality assessment (SQA) tool and its application in video assessments of MITG. This will serve SQA in prospective and randomized studies to ensure optimized surgical performance [42]. The results of the applied SQA will also be used to develop artificial intelligence-based algorithms for automation of SQA. The long-term aims are to determine an SQA of this technique through video-based learning to ensure standardization and improve patient outcomes after MITG for oncological indications. Furthermore, the SQA tool could be used as an intraoperative guide for residents or young surgeons, with the final aim to shorten the learning curve and improve intra- and postoperative results. The predefined surgical steps that emphasize the most important aspects of LND of each lymph node station in MITG for gastric cancer could provide valuable structure in training young surgeons to master this procedure and ensure the best possible patient outcomes through technical impeccability.
In conclusion, this is the first study to determine the crucial technical steps in LND in MITG, deconstructing the integral elements within a complex minimally invasive procedure. It has identified the key technical steps of LND and general aspects of anastomosis creation required to perform adequate MITG for oncological indications by soliciting international expert opinion through a three-round Delphi consensus method. These statements should serve the standardization of the MITG and, through that, the improvement of oncological outcomes through adequate LND.

Acknowledgements

We want to thank the EAES Research Sandpit Panel members, Prof. George Hanna, Prof. Tan Arulampalam, Prof. Sheraz Markar, Suzanne S Gisbertz, and Christos Kontovounisios for choosing and supporting our project.

Declarations

Disclosures

Hans F Fuchs has the following conflicts of interest to disclose: Medtronic: Advisory Board; Stryker: Advisory Board; Intuitive Surgical: Educational Grant (ESOMAP trial); Teaching Courses (EAES). Amila Cizmic, Ivan Romic, Andrea Balla, Nicolò Barabino, Gabriele Anania, Gian Luca Baiocchi, Branko Bakula, Carmen Balagué, Felix Berlth, Vasile Bintintan, Umberto Bracale, Jan-Hendrik Egberts, Suzanne S Gisbertz, Ines Gockel, Peter Grimminger, Richard van Hillegersberg, Noriyuki Inaki, Arul Immanuel, Daniel Korr, Philipp Lingohr, Pietro Mascagni, Nathaniel Melling, Marco Milone, Yoav Mintz, Salvador Morales-Conde, Yusef Moulla, Beat P Müller-Stich, Kiyokazu Nakajima, Magnus Nilsson, Matthias Reeh, Pierpaolo Sileri, Eduardo M Targarona, Yuki Ushimaru, Young-Woo Kim, Sheraz Markar, Felix Nickel, Anuja T Mitra have no conflicts of interest or financial ties to disclose.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

Die Chirurgie

Print-Titel

Das Abo mit mehr Tiefe

Mit der Zeitschrift Die Chirurgie erhalten Sie zusätzlich Online-Zugriff auf weitere 43 chirurgische Fachzeitschriften, CME-Fortbildungen, Webinare, Vorbereitungskursen zur Facharztprüfung und die digitale Enzyklopädie e.Medpedia.

Bis 30. April 2024 bestellen und im ersten Jahr nur 199 € zahlen!

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Literatur
1.
Zurück zum Zitat Wong MCS, Huang J, Chan PSF, Choi P, Lao XQ, Chan SM et al (2021) Global incidence and mortality of gastric cancer, 1980–2018. JAMA Netw Open 4(7):e2118457PubMedPubMedCentralCrossRef Wong MCS, Huang J, Chan PSF, Choi P, Lao XQ, Chan SM et al (2021) Global incidence and mortality of gastric cancer, 1980–2018. JAMA Netw Open 4(7):e2118457PubMedPubMedCentralCrossRef
2.
Zurück zum Zitat Wang Y, Zhang L, Yang Y, Lu S, Chen H (2021) Progress of gastric cancer surgery in the era of precision medicine. Int J Biol Sci 17(4):1041–1049PubMedPubMedCentralCrossRef Wang Y, Zhang L, Yang Y, Lu S, Chen H (2021) Progress of gastric cancer surgery in the era of precision medicine. Int J Biol Sci 17(4):1041–1049PubMedPubMedCentralCrossRef
3.
Zurück zum Zitat Yang WJ, Zhao HP, Yu Y, Wang JH, Guo L, Liu JY et al (2023) Updates on global epidemiology, risk and prognostic factors of gastric cancer. World J Gastroenterol 29(16):2452–2468PubMedPubMedCentralCrossRef Yang WJ, Zhao HP, Yu Y, Wang JH, Guo L, Liu JY et al (2023) Updates on global epidemiology, risk and prognostic factors of gastric cancer. World J Gastroenterol 29(16):2452–2468PubMedPubMedCentralCrossRef
4.
Zurück zum Zitat Straatman J, van der Wielen N, Cuesta MA, de Lange-de Klerk ES, Jansma EP, van der Peet DL (2016) Minimally invasive versus open total gastrectomy for gastric cancer: a systematic review and meta-analysis of short-term outcomes and completeness of resection : surgical techniques in gastric cancer. World J Surg 40(1):148–157PubMedCrossRef Straatman J, van der Wielen N, Cuesta MA, de Lange-de Klerk ES, Jansma EP, van der Peet DL (2016) Minimally invasive versus open total gastrectomy for gastric cancer: a systematic review and meta-analysis of short-term outcomes and completeness of resection : surgical techniques in gastric cancer. World J Surg 40(1):148–157PubMedCrossRef
5.
Zurück zum Zitat de Jongh C, Triemstra L, van der Veen A, Brosens LAA, Luyer MDP, Stoot J et al (2022) Pattern of lymph node metastases in gastric cancer: a side-study of the multicenter LOGICA-trial. Gastric Cancer 25(6):1060–1072PubMedPubMedCentralCrossRef de Jongh C, Triemstra L, van der Veen A, Brosens LAA, Luyer MDP, Stoot J et al (2022) Pattern of lymph node metastases in gastric cancer: a side-study of the multicenter LOGICA-trial. Gastric Cancer 25(6):1060–1072PubMedPubMedCentralCrossRef
6.
Zurück zum Zitat Zhang H, Sang J, Liu F (2017) Recognition of specialization of minimally invasive treatment for gastric cancer in the era of precision medicine. Zhonghua Wei Chang Wai Ke Za Zhi 20(8):847–851PubMed Zhang H, Sang J, Liu F (2017) Recognition of specialization of minimally invasive treatment for gastric cancer in the era of precision medicine. Zhonghua Wei Chang Wai Ke Za Zhi 20(8):847–851PubMed
7.
Zurück zum Zitat Jiao J, Liu S, Chen C, Maimaiti A, He Q, Hu S et al (2020) Comparative study of laparoscopic radical gastrectomy and open radical gastrectomy. J Minim Access Surg 16(1):41–46PubMedCrossRef Jiao J, Liu S, Chen C, Maimaiti A, He Q, Hu S et al (2020) Comparative study of laparoscopic radical gastrectomy and open radical gastrectomy. J Minim Access Surg 16(1):41–46PubMedCrossRef
8.
Zurück zum Zitat van der Wielen N, Daams F, Rosati R, Parise P, Weitz J, Reissfelder C et al (2022) Health related quality of life following open versus minimally invasive total gastrectomy for cancer: results from a randomized clinical trial. Eur J Surg Oncol 48(3):553–560PubMedCrossRef van der Wielen N, Daams F, Rosati R, Parise P, Weitz J, Reissfelder C et al (2022) Health related quality of life following open versus minimally invasive total gastrectomy for cancer: results from a randomized clinical trial. Eur J Surg Oncol 48(3):553–560PubMedCrossRef
10.
Zurück zum Zitat Ribeiro U Jr, Dias AR, Ramos M, Yagi OK, Oliveira RJ, Pereira MA et al (2022) Short-term surgical outcomes of robotic gastrectomy compared to open gastrectomy for patients with gastric cancer: a randomized trial. J Gastrointest Surg 26(12):2477–2485PubMedCrossRef Ribeiro U Jr, Dias AR, Ramos M, Yagi OK, Oliveira RJ, Pereira MA et al (2022) Short-term surgical outcomes of robotic gastrectomy compared to open gastrectomy for patients with gastric cancer: a randomized trial. J Gastrointest Surg 26(12):2477–2485PubMedCrossRef
11.
Zurück zum Zitat Tsekrekos A, Vossen LE, Lundell L, Jeremiasen M, Johnsson E, Hedberg J et al (2023) Improved survival after laparoscopic compared to open gastrectomy for advanced gastric cancer: a Swedish population-based cohort study. Gastric Cancer 26(3):467–477PubMedPubMedCentralCrossRef Tsekrekos A, Vossen LE, Lundell L, Jeremiasen M, Johnsson E, Hedberg J et al (2023) Improved survival after laparoscopic compared to open gastrectomy for advanced gastric cancer: a Swedish population-based cohort study. Gastric Cancer 26(3):467–477PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat Kitano S, Iso Y, Moriyama M, Sugimachi K (1994) Laparoscopy-assisted Billroth I gastrectomy. Surg Laparosc Endosc 4(2):146–148PubMed Kitano S, Iso Y, Moriyama M, Sugimachi K (1994) Laparoscopy-assisted Billroth I gastrectomy. Surg Laparosc Endosc 4(2):146–148PubMed
13.
Zurück zum Zitat Kitano S, Iso Y, Moriyama M, Sugimachi K (1994) Laparoscopy-assisted Billroth I gastrectomy. Surg Laparosc Endosc Percutan Tech 4(2):146–148 Kitano S, Iso Y, Moriyama M, Sugimachi K (1994) Laparoscopy-assisted Billroth I gastrectomy. Surg Laparosc Endosc Percutan Tech 4(2):146–148
14.
Zurück zum Zitat Beyer K, Baukloh AK, Kamphues C, Seeliger H, Heidecke CD, Kreis ME et al (2019) Laparoscopic versus open gastrectomy for locally advanced gastric cancer: a systematic review and meta-analysis of randomized controlled studies. World J Surg Oncol 17(1):68PubMedPubMedCentralCrossRef Beyer K, Baukloh AK, Kamphues C, Seeliger H, Heidecke CD, Kreis ME et al (2019) Laparoscopic versus open gastrectomy for locally advanced gastric cancer: a systematic review and meta-analysis of randomized controlled studies. World J Surg Oncol 17(1):68PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat Shi Y, Xu X, Zhao Y, Qian F, Tang B, Hao Y et al (2019) Long-term oncologic outcomes of a randomized controlled trial comparing laparoscopic versus open gastrectomy with D2 lymph node dissection for advanced gastric cancer. Surgery 165(6):1211–1216PubMedCrossRef Shi Y, Xu X, Zhao Y, Qian F, Tang B, Hao Y et al (2019) Long-term oncologic outcomes of a randomized controlled trial comparing laparoscopic versus open gastrectomy with D2 lymph node dissection for advanced gastric cancer. Surgery 165(6):1211–1216PubMedCrossRef
16.
Zurück zum Zitat Shi Y, Xu X, Zhao Y, Qian F, Tang B, Hao Y et al (2018) Short-term surgical outcomes of a randomized controlled trial comparing laparoscopic versus open gastrectomy with D2 lymph node dissection for advanced gastric cancer. Surg Endosc 32(5):2427–2433PubMedCrossRef Shi Y, Xu X, Zhao Y, Qian F, Tang B, Hao Y et al (2018) Short-term surgical outcomes of a randomized controlled trial comparing laparoscopic versus open gastrectomy with D2 lymph node dissection for advanced gastric cancer. Surg Endosc 32(5):2427–2433PubMedCrossRef
17.
Zurück zum Zitat van der Veen A, Brenkman HJF, Seesing MFJ, Haverkamp L, Luyer MDP, Nieuwenhuijzen GAP et al (2021) Laparoscopic versus open gastrectomy for gastric cancer (LOGICA): a multicenter randomized clinical trial. J Clin Oncol 39(9):978–989PubMedCrossRef van der Veen A, Brenkman HJF, Seesing MFJ, Haverkamp L, Luyer MDP, Nieuwenhuijzen GAP et al (2021) Laparoscopic versus open gastrectomy for gastric cancer (LOGICA): a multicenter randomized clinical trial. J Clin Oncol 39(9):978–989PubMedCrossRef
18.
Zurück zum Zitat van der Wielen N, Daams F, Rosati R, Parise P, Weitz J, Reissfelder C et al (2023) Three-year survival and distribution of lymph node metastases in gastric cancer following neoadjuvant chemotherapy: results from a European randomized clinical trial. Surg Endosc 37(9):7317–7324PubMedPubMedCentralCrossRef van der Wielen N, Daams F, Rosati R, Parise P, Weitz J, Reissfelder C et al (2023) Three-year survival and distribution of lymph node metastases in gastric cancer following neoadjuvant chemotherapy: results from a European randomized clinical trial. Surg Endosc 37(9):7317–7324PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat Kim W, Kim HH, Han SU, Kim MC, Hyung WJ, Ryu SW et al (2016) Decreased morbidity of laparoscopic distal gastrectomy compared with open distal gastrectomy for stage I gastric cancer: short-term outcomes from a multicenter randomized controlled trial (KLASS-01). Ann Surg 263(1):28–35PubMedCrossRef Kim W, Kim HH, Han SU, Kim MC, Hyung WJ, Ryu SW et al (2016) Decreased morbidity of laparoscopic distal gastrectomy compared with open distal gastrectomy for stage I gastric cancer: short-term outcomes from a multicenter randomized controlled trial (KLASS-01). Ann Surg 263(1):28–35PubMedCrossRef
20.
Zurück zum Zitat van der Wielen N, Straatman J, Daams F, Rosati R, Parise P, Weitz J et al (2021) Open versus minimally invasive total gastrectomy after neoadjuvant chemotherapy: results of a European randomized trial. Gastric Cancer 24(1):258–271PubMedCrossRef van der Wielen N, Straatman J, Daams F, Rosati R, Parise P, Weitz J et al (2021) Open versus minimally invasive total gastrectomy after neoadjuvant chemotherapy: results of a European randomized trial. Gastric Cancer 24(1):258–271PubMedCrossRef
21.
Zurück zum Zitat Nuytens F, Dabakuyo-Yonli TS, Meunier B, Gagnière J, Collet D, D’Journo XB et al (2021) Five-year survival outcomes of hybrid minimally invasive esophagectomy in esophageal cancer: results of the MIRO randomized clinical trial. JAMA Surg 156(4):323–332PubMedPubMedCentralCrossRef Nuytens F, Dabakuyo-Yonli TS, Meunier B, Gagnière J, Collet D, D’Journo XB et al (2021) Five-year survival outcomes of hybrid minimally invasive esophagectomy in esophageal cancer: results of the MIRO randomized clinical trial. JAMA Surg 156(4):323–332PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat Hyung WJ, Yang HK, Park YK, Lee HJ, An JY, Kim W et al (2020) Long-term outcomes of laparoscopic distal gastrectomy for locally advanced gastric cancer: The KLASS-02-RCT randomized clinical trial. J Clin Oncol 38(28):3304–3313PubMedCrossRef Hyung WJ, Yang HK, Park YK, Lee HJ, An JY, Kim W et al (2020) Long-term outcomes of laparoscopic distal gastrectomy for locally advanced gastric cancer: The KLASS-02-RCT randomized clinical trial. J Clin Oncol 38(28):3304–3313PubMedCrossRef
24.
Zurück zum Zitat Seika P, Biebl M, Raakow J, Kröll D, Çetinkaya-Hosgör C, Thuss-Patience P et al (2022) The learning curve for hand-assisted laparoscopic total gastrectomy in gastric cancer patients. J Clin Med 11(22):6841PubMedPubMedCentralCrossRef Seika P, Biebl M, Raakow J, Kröll D, Çetinkaya-Hosgör C, Thuss-Patience P et al (2022) The learning curve for hand-assisted laparoscopic total gastrectomy in gastric cancer patients. J Clin Med 11(22):6841PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat de Steur WO, Hartgrink HH, Dikken JL, Putter H, van de Velde CJ (2015) Quality control of lymph node dissection in the Dutch Gastric Cancer Trial. Br J Surg 102(11):1388–1393PubMedCrossRef de Steur WO, Hartgrink HH, Dikken JL, Putter H, van de Velde CJ (2015) Quality control of lymph node dissection in the Dutch Gastric Cancer Trial. Br J Surg 102(11):1388–1393PubMedCrossRef
26.
Zurück zum Zitat Han SU, Hur H, Lee HJ, Cho GS, Kim MC, Park YK et al (2021) Surgeon quality control and standardization of D2 lymphadenectomy for gastric cancer: a prospective multicenter observational study (KLASS-02-QC). Ann Surg 273(2):315–324PubMedCrossRef Han SU, Hur H, Lee HJ, Cho GS, Kim MC, Park YK et al (2021) Surgeon quality control and standardization of D2 lymphadenectomy for gastric cancer: a prospective multicenter observational study (KLASS-02-QC). Ann Surg 273(2):315–324PubMedCrossRef
27.
Zurück zum Zitat Palter VN, MacRae HM, Grantcharov TP (2011) Development of an objective evaluation tool to assess technical skill in laparoscopic colorectal surgery: a Delphi methodology. Am J Surg 201(2):251–259PubMedCrossRef Palter VN, MacRae HM, Grantcharov TP (2011) Development of an objective evaluation tool to assess technical skill in laparoscopic colorectal surgery: a Delphi methodology. Am J Surg 201(2):251–259PubMedCrossRef
28.
Zurück zum Zitat Brouwers MC, Kerkvliet K, Spithoff K (2016) The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines. BMJ 352:i1152PubMedPubMedCentralCrossRef Brouwers MC, Kerkvliet K, Spithoff K (2016) The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines. BMJ 352:i1152PubMedPubMedCentralCrossRef
29.
Zurück zum Zitat Williams PL, Webb C (1994) The Delphi technique: a methodological discussion. J Adv Nurs 19(1):180–186PubMedCrossRef Williams PL, Webb C (1994) The Delphi technique: a methodological discussion. J Adv Nurs 19(1):180–186PubMedCrossRef
30.
31.
Zurück zum Zitat Graham B, Regehr G, Wright JG (2003) Delphi as a method to establish consensus for diagnostic criteria. J Clin Epidemiol 56(12):1150–1156PubMedCrossRef Graham B, Regehr G, Wright JG (2003) Delphi as a method to establish consensus for diagnostic criteria. J Clin Epidemiol 56(12):1150–1156PubMedCrossRef
32.
Zurück zum Zitat Lazarus JV, Romero D, Kopka CJ, Karim SA, Abu-Raddad LJ, Almeida G et al (2022) A multinational Delphi consensus to end the COVID-19 public health threat. Nature 611(7935):332–345PubMedPubMedCentralCrossRef Lazarus JV, Romero D, Kopka CJ, Karim SA, Abu-Raddad LJ, Almeida G et al (2022) A multinational Delphi consensus to end the COVID-19 public health threat. Nature 611(7935):332–345PubMedPubMedCentralCrossRef
33.
Zurück zum Zitat Vogel C, Zwolinsky S, Griffiths C, Hobbs M, Henderson E, Wilkins E (2019) A Delphi study to build consensus on the definition and use of big data in obesity research. Int J Obes (Lond) 43(12):2573–2586PubMedCrossRef Vogel C, Zwolinsky S, Griffiths C, Hobbs M, Henderson E, Wilkins E (2019) A Delphi study to build consensus on the definition and use of big data in obesity research. Int J Obes (Lond) 43(12):2573–2586PubMedCrossRef
34.
Zurück zum Zitat Lam K, Abràmoff MD, Balibrea JM, Bishop SM, Brady RR, Callcut RA et al (2022) A Delphi consensus statement for digital surgery. NPJ Digit Med 5(1):100PubMedPubMedCentralCrossRef Lam K, Abràmoff MD, Balibrea JM, Bishop SM, Brady RR, Callcut RA et al (2022) A Delphi consensus statement for digital surgery. NPJ Digit Med 5(1):100PubMedPubMedCentralCrossRef
35.
Zurück zum Zitat Khamis NN, Satava RM, Alnassar SA, Kern DE (2016) A stepwise model for simulation-based curriculum development for clinical skills, a modification of the six-step approach. Surg Endosc 30(1):279–287PubMedCrossRef Khamis NN, Satava RM, Alnassar SA, Kern DE (2016) A stepwise model for simulation-based curriculum development for clinical skills, a modification of the six-step approach. Surg Endosc 30(1):279–287PubMedCrossRef
36.
Zurück zum Zitat Nakata K, Nagai E, Ohuchida K, Shimizu S, Tanaka M (2015) Technical feasibility of laparoscopic total gastrectomy with splenectomy for gastric cancer: clinical short-term and long-term outcomes. Surg Endosc 29(7):1817–1822PubMedCrossRef Nakata K, Nagai E, Ohuchida K, Shimizu S, Tanaka M (2015) Technical feasibility of laparoscopic total gastrectomy with splenectomy for gastric cancer: clinical short-term and long-term outcomes. Surg Endosc 29(7):1817–1822PubMedCrossRef
37.
Zurück zum Zitat Haverkamp L, Brenkman HJ, Ruurda JP, Ten Kate FJ, van Hillegersberg R (2016) The oncological value of omentectomy in gastrectomy for cancer. J Gastrointest Surg 20(5):885–890PubMedPubMedCentralCrossRef Haverkamp L, Brenkman HJ, Ruurda JP, Ten Kate FJ, van Hillegersberg R (2016) The oncological value of omentectomy in gastrectomy for cancer. J Gastrointest Surg 20(5):885–890PubMedPubMedCentralCrossRef
38.
Zurück zum Zitat Metwally IH, Abdelkhalek M, Shetiwy M, Elalfy AF, Abouzid A, Elbalka SS et al (2020) Significance of omental infiltration in gastric cancer patients: a retrospective cohort study. J Gastrointest Cancer 51(3):861–867PubMedCrossRef Metwally IH, Abdelkhalek M, Shetiwy M, Elalfy AF, Abouzid A, Elbalka SS et al (2020) Significance of omental infiltration in gastric cancer patients: a retrospective cohort study. J Gastrointest Cancer 51(3):861–867PubMedCrossRef
39.
Zurück zum Zitat Kong M, Chen H, Zhang R, Sheng H, Li L (2022) Overall survival advantage of omentum preservation over omentectomy for advanced gastric cancer: a systematic review and meta-analysis. World J Surg 46(8):1952–1961PubMedCrossRef Kong M, Chen H, Zhang R, Sheng H, Li L (2022) Overall survival advantage of omentum preservation over omentectomy for advanced gastric cancer: a systematic review and meta-analysis. World J Surg 46(8):1952–1961PubMedCrossRef
40.
Zurück zum Zitat Kim TH, Kim IH, Kang SJ, Choi M, Kim BH, Eom BW et al (2023) Korean practice guidelines for gastric cancer 2022: an evidence-based, multidisciplinary approach. J Gastric Cancer 23(1):3–106PubMedPubMedCentralCrossRef Kim TH, Kim IH, Kang SJ, Choi M, Kim BH, Eom BW et al (2023) Korean practice guidelines for gastric cancer 2022: an evidence-based, multidisciplinary approach. J Gastric Cancer 23(1):3–106PubMedPubMedCentralCrossRef
41.
Zurück zum Zitat Renna MS, Grzeda MT, Bailey J, Hainsworth A, Ourselin S, Ebner M et al (2023) Intraoperative bowel perfusion assessment methods and their effects on anastomotic leak rates: meta-analysis. Br J Surg 110(9):1131–1142PubMedPubMedCentralCrossRef Renna MS, Grzeda MT, Bailey J, Hainsworth A, Ourselin S, Ebner M et al (2023) Intraoperative bowel perfusion assessment methods and their effects on anastomotic leak rates: meta-analysis. Br J Surg 110(9):1131–1142PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Nickel F, Studier-Fischer A, Hausmann D, Klotz R, Vogel-Adigozalov SL, Tenckhoff S et al (2022) Minimally invasivE versus open total GAstrectomy (MEGA): study protocol for a multicentre randomised controlled trial (DRKS00025765). BMJ Open 12(10):e064286PubMedPubMedCentralCrossRef Nickel F, Studier-Fischer A, Hausmann D, Klotz R, Vogel-Adigozalov SL, Tenckhoff S et al (2022) Minimally invasivE versus open total GAstrectomy (MEGA): study protocol for a multicentre randomised controlled trial (DRKS00025765). BMJ Open 12(10):e064286PubMedPubMedCentralCrossRef
Metadaten
Titel
An international Delphi consensus for surgical quality assessment of lymphadenectomy and anastomosis in minimally invasive total gastrectomy for gastric cancer
verfasst von
Amila Cizmic
Ivan Romic
Andrea Balla
Nicolò Barabino
Gabriele Anania
Gian Luca Baiocchi
Branko Bakula
Carmen Balagué
Felix Berlth
Vasile Bintintan
Umberto Bracale
Jan-Hendrik Egberts
Hans F. Fuchs
Suzanne S. Gisbertz
Ines Gockel
Peter Grimminger
Richard van Hillegersberg
Noriyuki Inaki
Arul Immanuel
Daniel Korr
Philipp Lingohr
Pietro Mascagni
Nathaniel Melling
Marco Milone
Yoav Mintz
Salvador Morales-Conde
Yusef Moulla
Beat P. Müller-Stich
Kiyokazu Nakajima
Magnus Nilsson
Matthias Reeh
Pierpaolo Sileri
Eduardo M. Targarona
Yuki Ushimaru
Young-Woo Kim
Sheraz Markar
Felix Nickel
Anuja T. Mitra
Publikationsdatum
26.12.2023
Verlag
Springer US
Erschienen in
Surgical Endoscopy / Ausgabe 2/2024
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-023-10614-9

Weitere Artikel der Ausgabe 2/2024

Surgical Endoscopy 2/2024 Zur Ausgabe

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.